Valuation: MindMaze Therapeutics Holding SA

Market Cap 24.11M 29.52M 25.93M 22.13M 41.57M 2.84B 42.21M 286M 112M 1.4B 111M 108M 4.83B P/E 2026 *
-3.51x
P/E 2027 * 1.23x
Enterprise Value 15.69M 19.21M 16.87M 14.4M 27.06M 1.85B 27.47M 186M 72.8M 910M 72.12M 70.57M 3.14B EV / Sales 2026 *
2.66x
EV / Sales 2027 * 0.11x
Free-Float
38.51%
Yield 2026 *
-
Yield 2027 * -
1 day+3.67%
1 week-1.99%
Current month-21.00%
1 month-28.18%
3 months-47.51%
6 months-86.68%
Current year-91.68%
1 week 0.15
Extreme 0.1518
0.17
1 month 0.15
Extreme 0.1518
0.26
Current year 0.15
Extreme 0.1518
1.87
1 year 0.15
Extreme 0.1518
2.92
3 years 0.15
Extreme 0.1518
2.92
5 years 0.15
Extreme 0.1518
2.92
10 years 0.15
Extreme 0.1518
2.92
Date Insider Type Main position Quantity % Market Cap.
12/19/25 Sell 281,968 0.1830%
12/19/25 Sell 140,000 0.0908%
12/19/25 Sell 52,162 0.0338%
Change 5-day change 1-year change 3-year change Capi.($)
+3.67%-1.99% - - 29.52M
+1.07%-3.49%-3.35%+10.44% 46.86B
+0.25%+1.65%+399.22%+634.87% 40.23B
-0.27%+4.45%+11.81%+65.64% 36.23B
+0.35%+0.87%+4.46%-10.16% 34.72B
+3.14%+1.02%+4.76%+40.92% 27.89B
-0.73%+11.84%+34.39%+134.36% 16.79B
+0.47%-2.74% - - 16.74B
+0.42%-5.52%-3.43%+9.03% 13.12B
-2.68%-2.49%-11.36%-33.61% 12.7B
Average +0.57%+0.55%+54.56%+106.44% 24.53B
Weighted average by Cap. +0.48%+0.91%+74.42%+136.27%

Financials

2026 *2027 *
Net sales 5.9M 7.22M 6.34M 5.41M 10.17M 696M 10.33M 70.06M 27.37M 342M 27.12M 26.53M 1.18B 43.19M 52.87M 46.44M 39.63M 74.46M 5.09B 75.61M 513M 200M 2.5B 198M 194M 8.65B
Net income -7.81M -9.56M -8.4M -7.17M -13.47M -921M -13.67M -92.75M -36.24M -453M -35.9M -35.13M -1.57B 24.83M 30.4M 26.7M 22.78M 42.81M 2.93B 43.47M 295M 115M 1.44B 114M 112M 4.98B
Net Debt -8.42M -10.31M -9.05M -7.73M -14.52M -993M -14.74M -99.97M -39.06M -488M -38.69M -37.86M -1.69B -19.27M -23.59M -20.72M -17.68M -33.22M -2.27B -33.73M -229M -89.4M -1.12B -88.56M -86.65M -3.86B
Logo MindMaze Therapeutics Holding SA
MindMaze Therapeutics Holding SA, formerly known as RELIEF THERAPEUTICS Holding SA, is a Switzerland-based company that engages in research, development, production, and sale of biotechnology, pharmaceutical, diagnostic, therapeutic, chemical, and cosmetic products. The Company acquires and manages patents, licenses, and intellectual property, provides preclinical, clinical, and regulatory services, and may establish subsidiaries worldwide. The Company also participates in the acquisition, holding, and financing of interests in companies, offers management services to affiliates, and develops scientific and economic solutions for disease treatment and therapeutic approaches. Additionally, the Company may acquire, hold, and sell trademarks and other IP rights globally, and provide or obtain financing through loans or guarantees to support its corporate purpose.
Employees
10
Date Price Change Volume
26-07-24 CHF 0.1580 +3.67% 931,243
26-07-23 CHF 0.1524 -3.42% 465,585
26-07-22 CHF 0.1578 +0.38% 946,836
26-07-21 CHF 0.1572 -0.25% 484,462
26-07-20 CHF 0.1576 -2.23% 616,675
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
CCC

Annual profits - Rate of surprise